Combined inhibition of CDK4/6 and AKT is highly active against the luminal androgen receptor (LAR) subtype of triple negative breast cancer (TNBC)

被引：1
|
作者：
Chica-Parrado, Maria del Rosario
Kin, Gun Min
Lin, Chang-Ching
Lee, Kyung-Min
Napolitano, Fabiana
Ye, Dan
Bikorimana, Emmanuel
Mendirata, Saurabh
Hanker, Ariella
Arteaga, Carlos L.
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 07期
关键词：
D O I：
10.1158/1538-7445.AM2023-5483
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5483
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Overcoming Therapeutic Resistance of Triple Positive Breast Cancer with CDK4/6 Inhibition
    Schedin, Troy B.
    Borges, Virginia F.
    Shagisultanova, Elena
    INTERNATIONAL JOURNAL OF BREAST CANCER, 2018, 2018
  • [32] CDK4/6 inhibition blocks effects of IGFs and insulin in estrogen receptor positive and triple negative breast cancers
    Hoff, Katelyn
    Sachdev, Deepali
    CANCER RESEARCH, 2018, 78 (13)
  • [33] Inhibiting eIF4E phosphorylation sensitizes triple-negative breast cancer to CDK4/6 inhibition
    Deng, Qiyun
    Amiri, Mehdi
    Piric, Anastasija Ana
    Bagherian, Yasaman
    Li, Zilan
    Huang, Sidong
    Pollak, Michael
    Sonenberg, Nahum
    MOLECULAR CANCER THERAPEUTICS, 2024, 23 (06)
  • [34] Single-Cell Dynamics Determines Response to CDK4/6 Inhibition in Triple-Negative Breast Cancer
    Asghar, Uzma S.
    Barr, Alexis R.
    Cutts, Ros
    Beaney, Matthew
    Babina, Irina
    Sampath, Deepak
    Giltnane, Jennifer
    Lacap, Jennifer Arca
    Crocker, Lisa
    Young, Amy
    Pearson, Alex
    Herrera-Abreu, Maria Teresa
    Bakal, Chris
    Turner, Nicholas C.
    CLINICAL CANCER RESEARCH, 2017, 23 (18) : 5561 - 5572
  • [35] CREBBP alterations lead to CDK4/6 inhibitor sensitivity in triple negative breast cancer
    Natrajan, Rachael
    CANCER RESEARCH, 2020, 80 (04)
  • [36] Phase II clinical trial of palbociclib and binimetinib in advanced triple-negative breast cancer (TNBC) with hyperactivation of ERK and/or CDK4/6
    Sanchez-Bayona, Rodrigo
    Cortes, Alfonso
    Cejalvo, Juan Miguel
    Manso, Luis
    Morales, Serafin
    Garcia-Saenz, Jose A.
    Silva, Jorge
    Guerra, Juan A.
    Malon-Gimenez, Diego
    Mouron, Silvana
    Caleiras, Eduardo
    Quintela-Fandino, Miguel
    CANCER RESEARCH, 2024, 84 (09)
  • [37] Activity of Combined Androgen Receptor Antagonism and Cell Cycle Inhibition in Androgen Receptor Positive Triple Negative Breast Cancer
    Christenson, Jessica L.
    O'Neill, Kathleen, I
    Williams, Michelle M.
    Spoelstra, Nicole S.
    Jones, Kenneth L.
    Trahan, G. Devon
    Reese, Jordan
    van Patten, Elaina T.
    Elias, Anthony
    Eisner, Joel R.
    Richer, Jennifer K.
    MOLECULAR CANCER THERAPEUTICS, 2021, 20 (06) : 1062 - 1071
  • [38] The novel potential of palbociclib (CDK4/6 inhibitor) in the treatment of triple-negative breast cancer
    Kashiwagi, Shinichiro
    Asano, Yuka
    Goto, Wataru
    Takada, Koji
    Takashima, Tsutomu
    Morisaki, Tamami
    Noda, Satoru
    Onoda, Naoyoshi
    Hirakawa, Kosei
    Ohira, Masaichi
    CANCER RESEARCH, 2017, 77
  • [39] The novel potential of palbociclib (CDK4/6 inhibitor) in the treatment of triple-negative breast cancer
    Asano, Yuka
    Kashiwagi, Shinichiro
    Goto, Wataru
    Takahashi, Katsuyuki
    Takashima, Tsutomu
    Noda, Satoru
    Onoda, Naoyoshi
    Tomita, Shuhei
    Hirakawa, Kosei
    Ohira, Masaichi
    CANCER RESEARCH, 2017, 77
  • [40] Increased lysosomal biomass is responsible for the resistance of triple-negative breast cancers to CDK4/6 inhibition
    Fassl, Anne
    Brain, Christopher
    Abu-Remaileh, Monther
    Stukan, Iga
    Butter, Deborah
    Stepien, Piotr
    Feit, Avery S.
    Bergholz, Johann
    Michowski, Wojciech
    Otto, Tobias
    Sheng, Qing
    Loo, Alice
    Michael, Walter
    Tiedt, Ralph
    DeAngelis, Carmine
    Schiff, Rachel
    Jiang, Baishan
    Jovanovic, Bojana
    Nowak, Karolina
    Ericsson, Maria
    Cameron, Michael
    Gray, Nathanael
    Dillon, Deborah
    Zhao, Jean J.
    Sabatini, David M.
    Jeselsohn, Rinath
    Brown, Myles
    Polyak, Kornelia
    Sicinski, Piotr
    SCIENCE ADVANCES, 2020, 6 (25):
12345